This strategy effectively disrupts the Fn-driven intestinal inflammatory cascade and oncogenic signaling pathways (notably the JAK/STAT, MAPK/ERK, and Wnt/β-catenin pathways), thereby providing potent intervention at the critical stage of the colorectal adenoma-carcinoma transition (Figure 4). Here, FN1 is linked to carcinoma.